Published in Transfus Med on June 01, 1994
Sexual transmission of hepatitis C virus infection. Sex Transm Infect (1998) 1.95
Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol (2005) 1.67
Anti-HCV prevalence in the general population of Lithuania. Med Sci Monit (2012) 0.78
Hepatitis C virus infection in Lebanese patients with B-cell non-Hodgkin's lymphoma. Eur J Epidemiol (2003) 0.76
Hepatitis C virus infection among blood donors: a many-faceted problem. Transfus Med (1994) 0.75
Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993-5. BMJ (1998) 0.75
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet (1998) 5.15
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Managing patients with lung cancer. New guidelines should improve standards of care. BMJ (1999) 3.65
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
HCV confirmatory testing of blood donors. Lancet (1991) 3.29
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
The structure of the major cell processes of isolated BHK21 fibroblasts. Exp Cell Res (1969) 3.27
Infection with hepatitis G virus among recipients of plasma products. Lancet (1996) 3.25
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10
Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97
The occurrence of microvilli during spreading and growth of BHK21-C13 fibroblasts. Exp Cell Res (1970) 2.97
The DNA of a minute virus of mice. J Gen Virol (1969) 2.93
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol (1994) 2.90
Viral hepatitis markers in blood donors and patients with a history of jaundice. Lancet (1980) 2.90
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol (1990) 2.68
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
A cumulative review of studies on travellers, their experience of illness and the implications of these findings. J Infect (1990) 2.50
Guidelines for autologous transfusion. II. Perioperative haemodilution and cell salvage. British Committee for Standards in Haematology Blood Transfusion Task Force. Autologous Transfusion Working Party. Br J Anaesth (1997) 2.49
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus. J Virol (1974) 2.19
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Defective particles in BHK cells infected with temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1971) 2.14
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13
Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07
HTLV-III antibody in Edinburgh drug addicts. Lancet (1985) 2.03
Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet (1990) 2.01
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol (2005) 1.98
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol (2007) 1.96
The DNAs of three parvoviruses. J Gen Virol (1970) 1.96
The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis (1995) 1.94
Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS (1991) 1.93
Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88
Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM (1996) 1.88
HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection. Lancet (1986) 1.88
Transmission of non-A, non-B hepatitis by pH4-treated intravenous immunoglobulin. Vox Sang (1989) 1.85
An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS (1989) 1.80
Birefringent filamentous organelle in BHK-21 cells and its possible role in cell spreading and motility. Science (1970) 1.78
Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut (1981) 1.77
Serological responses to infection with three different types of hepatitis C virus. Lancet (1991) 1.73
Vaccinia virus replication in enucleate BSC-1 cells: particle production and synthesis of viral DNA and proteins. J Virol (1974) 1.72
Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol (2008) 1.68
Confirmation of hepatitis C virus antibody in blood donors. J Med Virol (1993) 1.68
Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol (1999) 1.68